Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
FASEB J ; 35(7): e21712, 2021 07.
Article in English | MEDLINE | ID: mdl-34110637

ABSTRACT

Palmitic acid (PA) is a saturated fatty acid whose high consumption has been largely associated with the development of different metabolic alterations, such as insulin resistance, metabolic syndrome, and type 2 diabetes. Particularly in the brain, insulin signaling disruption has been linked to cognitive decline and is considered a risk factor for Alzheimer's disease. Cumulative evidence has demonstrated the participation of PA in the molecular cascade underlying cellular insulin resistance in peripheral tissues, but its role in the development of neuronal insulin resistance and the mechanisms involved are not fully understood. It has generally been accepted that the brain does not utilize fatty acids as a primary energy source, but recent evidence shows that neurons possess the machinery for fatty acid ß-oxidation. However, it is still unclear under what conditions neurons use fatty acids as energy substrates and the implications of their oxidative metabolism in modifying insulin-stimulated effects. In the present work, we have found that neurons differentiated from human neuroblastoma MSN exposed to high but nontoxic concentrations of PA generate ATP through mitochondrial metabolism, which is associated with an increase in the cytosolic Ca2+ and diminished insulin signaling in neurons. These findings reveal a novel mechanism by which saturated fatty acids produce Ca2+ entry and insulin resistance that may play a causal role in increasing neuronal vulnerability associated with metabolic diseases.


Subject(s)
Calcium/metabolism , Energy Metabolism/drug effects , Insulin Resistance/physiology , Neurons/drug effects , Palmitic Acid/pharmacology , Adenosine Triphosphate/metabolism , Cell Line, Tumor , Cytosol/drug effects , Cytosol/metabolism , Fatty Acids/pharmacology , Humans , Insulin/metabolism , Mitochondria/drug effects , Mitochondria/metabolism , Neuroblastoma/metabolism , Neurons/metabolism , Signal Transduction/drug effects
2.
Int J Mol Sci ; 19(12)2018 Nov 23.
Article in English | MEDLINE | ID: mdl-30477115

ABSTRACT

Phosphoinositide 3-kinase (PI3K) signaling contributes to a variety of processes, mediating many aspects of cellular function, including nutrient uptake, anabolic reactions, cell growth, proliferation, and survival. Less is known regarding its critical role in neuronal physiology, neuronal metabolism, tissue homeostasis, and the control of gene expression in the central nervous system in healthy and diseased states. The aim of the present work is to review cumulative evidence regarding the participation of PI3K pathways in neuronal function, focusing on their role in neuronal metabolism and transcriptional regulation of genes involved in neuronal maintenance and plasticity or on the expression of pathological hallmarks associated with neurodegeneration.


Subject(s)
Neurons/metabolism , Phosphatidylinositol 3-Kinases/metabolism , Signal Transduction , Animals , Autophagy , Epigenesis, Genetic , Gene Expression Regulation , Humans , Inflammation/genetics , Inflammation/metabolism , Neurodegenerative Diseases/metabolism , Proto-Oncogene Proteins c-akt/metabolism , Synaptic Transmission
3.
Endocrinol Diabetes Metab ; 6(1): e386, 2023 01.
Article in English | MEDLINE | ID: mdl-36321333

ABSTRACT

INTRODUCTION: Saturated fatty acids (FAs) are the main component of high-fat diets (HFDs), and high consumption has been associated with the development of insulin resistance, endoplasmic reticulum stress and mitochondrial dysfunction in neuronal cells. In particular, the reduction in neuronal insulin signaling seems to underlie the development of cognitive impairments and has been considered a risk factor for Alzheimer's disease (AD). METHODS: This review summarized and critically analyzed the research that has impacted the field of saturated FA metabolism in neurons. RESULTS: We reviewed the mechanisms for free FA transport from the systemic circulation to the brain and how they impact neuronal metabolism. Finally, we focused on the molecular and the physiopathological consequences of brain exposure to the most abundant FA in the HFD, palmitic acid (PA). CONCLUSION: Understanding the mechanisms that lead to metabolic alterations in neurons induced by saturated FAs could help to develop several strategies for the prevention and treatment of cognitive impairment associated with insulin resistance, metabolic syndrome, or type II diabetes.


Subject(s)
Diabetes Mellitus, Type 2 , Insulin Resistance , Humans , Fatty Acids/adverse effects , Fatty Acids/metabolism , Insulin Resistance/physiology , Energy Metabolism , Brain/metabolism , Neurons/metabolism
4.
Neurochem Int ; 110: 75-83, 2017 Nov.
Article in English | MEDLINE | ID: mdl-28919254

ABSTRACT

The high consumption of saturated lipids has been largely associated with the increasing prevalence of metabolic diseases. In particular, saturated fatty acids such as palmitic acid (PA) have been implicated in the development of insulin resistance in peripheral tissues. However, how neurons develop insulin resistance in response to lipid overload is not fully understood. Here, we used cultured rat cortical neurons and differentiated human neuroblastoma cells to demonstrate that PA blocks insulin-induced metabolic activation, inhibits the activation of the insulin/PI3K/Akt pathway and activates mTOR kinase downstream of Akt. Despite the fact that fatty acids are not normally used as a significant source of fuel by neural cells, we also found that short-term neuronal exposure to PA reduces the NAD+/NADH ratio, indicating that PA modifies the neuronal energy balance. Finally, inhibiting mitochondrial ROS production with mitoTEMPO prevented the deleterious effect of PA on insulin signaling. This work provides novel evidence of the mechanisms behind saturated fatty acid-induced insulin resistance and its metabolic consequences on neuronal cells.


Subject(s)
Insulin/metabolism , Palmitic Acid/pharmacology , Phosphatidylinositol 3-Kinases/metabolism , Proto-Oncogene Proteins c-akt/metabolism , Reactive Oxygen Species/metabolism , TOR Serine-Threonine Kinases/metabolism , Animals , Cell Differentiation/drug effects , Cell Differentiation/physiology , Cell Line, Tumor , Cells, Cultured , Energy Metabolism/drug effects , Energy Metabolism/physiology , Humans , Insulin Antagonists/pharmacology , Mitochondria/drug effects , Mitochondria/metabolism , Neuroblastoma/metabolism , Phosphoinositide-3 Kinase Inhibitors , Proto-Oncogene Proteins c-akt/antagonists & inhibitors , Rats , Signal Transduction
SELECTION OF CITATIONS
SEARCH DETAIL